PaySign (NASDAQ:PAYS) and OmniComm Systems (OTCMKTS:OMCM) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.

Risk & Volatility

PaySign has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, OmniComm Systems has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500.

Valuation & Earnings

This table compares PaySign and OmniComm Systems’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PaySign $23.42 million 22.51 $2.57 million $0.09 123.11
OmniComm Systems $27.10 million 2.44 $3.69 million N/A N/A

OmniComm Systems has higher revenue and earnings than PaySign.

Analyst Recommendations

This is a breakdown of recent recommendations for PaySign and OmniComm Systems, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PaySign 0 1 3 0 2.75
OmniComm Systems 0 0 0 0 N/A

PaySign currently has a consensus price target of $12.50, suggesting a potential upside of 12.82%. Given PaySign’s higher possible upside, equities analysts plainly believe PaySign is more favorable than OmniComm Systems.

Insider and Institutional Ownership

24.4% of PaySign shares are held by institutional investors. 38.6% of PaySign shares are held by company insiders. Comparatively, 48.9% of OmniComm Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares PaySign and OmniComm Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PaySign 13.90% 66.14% 14.94%
OmniComm Systems -2.67% -13.18% -6.95%

Summary

PaySign beats OmniComm Systems on 8 of the 11 factors compared between the two stocks.

PaySign Company Profile

PaySign, Inc. provides prepaid card programs and processing services under the PaySign brand to corporations, government agencies, universities, and other organizations. The company offers various services, including transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through PaySign, a proprietary card-processing platform. It also develops prepaid card products for healthcare reimbursement payments, pharmaceutical assistance, donor compensation, corporate and incentive rewards, and expense reimbursement cards; and payroll or general purpose reloadable cards, as well as gift or incentive cards. In addition, the company offers Buy and Bill programs for patients to purchase directly from physician's office or through an infusion center for physician administered therapies; payment solution for source plasma collection centers; and PaySign Premier, a demand deposit account debit card, as well as customer service center and PaySign Communications Suite services. Its principal target markets for processing services comprise prepaid card issuers, retail and private-label issuers, small third-party processors, and small and mid-size financial institutions in the United States and internationally. The company was formerly known as 3PEA International, Inc. and changed its name to PaySign, Inc. in April 2019. PaySign, Inc. was incorporated in 1995 and is based in Henderson, Nevada.

OmniComm Systems Company Profile

OmniComm Systems, Inc., a healthcare technology company, provides Web-based electronic data capture (EDC), and eClinical software and services for pharmaceutical and biotechnology companies, clinical research organizations (CROs), and other clinical trial sponsors worldwide. It offers TrialMaster, which allows organizations conducting clinical trials to collect and manage the data over the Internet; TrialOne Phase I Clinic Automation, a software application suite that provides clinical trial site sponsors, study investigators, and study monitors with various tools to conduct the Phase I clinic operation; and IRTMaster, which offers interactive response technology in support of the randomization process in clinical trials. The company also provides eClinical Suite that comprises a set of tools for collecting and managing clinical data, including EDC for real-time entry and double data entry (DDE) for entry from paper originals; and Promasys, a clinical trial data management system for DDE and EDC, which is primarily used at research institutions for investigator-initiated trials. In addition, it offers Acuity, a clinical data aggregation and analytics platform that provides actionable insights into quality, risk, and performance of various aspects of clinical trials in real time. Further, the company provides consulting and professional services, such as project management, clinical services, training, custom configuration, system integration, standard operating procedures and implementation assistance, installation, and validation services, as well as application hosting and related support services. It sells its products through a direct sales force and relationships with CRO partners, as well as through co-marketing agreements with vendor and channel partners. OmniComm Systems, Inc. was founded in 1996 and is headquartered in Fort Lauderdale, Florida.

Receive News & Ratings for PaySign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PaySign and related companies with MarketBeat.com's FREE daily email newsletter.